Provided by Tiger Trade Technology Pte. Ltd.

Leverage Shares 2X Long PLUG Daily ETF

6.97
-0.3030-4.17%
Post-market: 6.980.0144+0.21%16:36 EDT
Volume:38.40K
Turnover:265.55K
Market Cap:3.80M
PE:- -
High:7.24
Open:6.87
Low:6.84
Close:7.27
52wk High:36.66
52wk Low:6.13
Shares:545.00K
Float Shares:545.00K
Volume Ratio:1.83
T/O Rate:7.05%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Options Volatility and Implied Earnings Moves This Week, August 10 – August 13, 2026

TIPRANKS
·
Aug 10

Plug Power Inc. Stock Rallies 5.3%, Outperforms Peers

Dow Jones
·
Aug 08

Plug Power Options Are Pricing a 13.5% Earnings Swing, Well Above Recent History

TIPRANKS
·
Aug 07

Plug Power management to meet with BTIG

TIPRANKS
·
Aug 07

Plug Power Earnings Preview: Can PLUG’s Turnaround Outpace Its Cash Burn?

TIPRANKS
·
Aug 06

Plug Power Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Aug 06

Plug Power Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 05

Plug Power Schedules Quarterly Results Call

Reuters
·
Aug 03

Plug Power to Announce 2026 Second Quarter Results on August 10, 2026

GlobeNewswire
·
Aug 03

Plug Power Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 31

Plug Power Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Jul 30

Plug Power Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Jul 28

Plug Power Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Jul 25

Plug Power Inc. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Jul 24

Plug Power Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Jul 23

Plug Power Inc. Stock Underperforms Monday When Compared to Competitors

Dow Jones
·
Jul 21

RBC Capital Reaffirms Their Hold Rating on Plug Power (PLUG)

TIPRANKS
·
Jul 19

Plug Power (PLUG) Receives a Sell from BMO Capital

TIPRANKS
·
Jul 17

Plug Power Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Jul 16

Rani Therapeutics Announces Positive Initial Phase 1a Data for RT-114 for the Treatment of Obesity, with Oral Bioavailability Exceeding Matched Subcutaneous Dosing

GlobeNewswire
·
Jul 15